Literature DB >> 2825737

Replication of plasmids derived from bovine papilloma virus type 1 and Epstein-Barr virus in cells in culture.

J Mecsas1, B Sugden.   

Abstract

The major components encoded by BPV-1 and EBV that act in plasmid replication of these viral DNAs in latently infected cells are now known. The minimal DNA sequences required in cis have been delineated, and the genes whose products are required in trans have been identified. The only required trans-acting gene of EBV, EBNA-1, has been shown to bind specifically to the cis-acting element, oriP. The current advanced understanding of plasmid replication of mtDNA and SV40 DNA is likely to aid in the selection of experiments that will assign functions to these components. In particular, it is exciting to contemplate the possible roles that transcription enhancers and the proteins that bind to these enhancers may perform in plasmid replication. Moreover, one can ask whether or not a virally encoded, site-specific DNA helicase participates in the replication of BPV-1 and EBV plasmids, as it does in SV40 DNA. Continued studies of the regulation of the segregation and the copy-number control of BPV-1 and EBV plasmids are likely to reveal other types of mechanisms, for which our knowledge of mtDNA and SV40 DNA replication does not provide precedents. Findings from these studies may aid not only in our understanding of the regulation of BPV-1 and EBV plasmid replication, but also in the regulation of chromosomal origins of replication.

Entities:  

Mesh:

Year:  1987        PMID: 2825737     DOI: 10.1146/annurev.cb.03.110187.000511

Source DB:  PubMed          Journal:  Annu Rev Cell Biol        ISSN: 0743-4634


  29 in total

1.  Enhancer effect of bovine papillomavirus E2 protein in replication of polyomavirus DNA.

Authors:  M Nilsson; M Forsberg; Z Y You; G Westin; G Magnusson
Journal:  Nucleic Acids Res       Date:  1991-12       Impact factor: 16.971

Review 2.  Relationship of eukaryotic DNA replication to committed gene expression: general theory for gene control.

Authors:  L P Villarreal
Journal:  Microbiol Rev       Date:  1991-09

3.  Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells.

Authors:  J L Yates; N Guan
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

4.  Interaction of Epstein-Barr virus nuclear antigen 1 with the viral latent origin of replication.

Authors:  J Hearing; Y Mülhaupt; S Harper
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

Review 5.  Vectors for cancer gene therapy.

Authors:  J Zhang; S J Russell
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

6.  Replication of bovine papillomavirus type 1 DNA initiates within an E2-responsive enhancer element.

Authors:  L Yang; M Botchan
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

Review 7.  Stability without a centromere.

Authors:  M P Calos
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

8.  Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus.

Authors:  D A Wysokenski; J L Yates
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

9.  Epstein-Barr virus replication studies and their application to vector design.

Authors:  P M Brickell; M S Patel
Journal:  Mol Biotechnol       Date:  1995-06       Impact factor: 2.695

10.  Random-choice replication of extrachromosomal bovine papillomavirus (BPV) molecules in heterogeneous, clonally derived BPV-infected cell lines.

Authors:  J B Ravnan; D M Gilbert; K G Ten Hagen; S N Cohen
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.